ROTA.shock Outcomes: Intravascular Lithotripsy vs. Rotational Atherectomy

At present, severe calcified coronary stenosis poses a significant challenge for PCI. A successful intervention will require plaque modification prior stenting, seeing as sub-expansion has been associated with worse clinical outcomes at followup. 

The tools normally used to treat these complex lesions include specialized balloons such as cutting, scoring, and high pressure balloons, as well as rotational (RA) and orbital atherectomy. However, these last two methods have limited effect in deep calcifications and have been associated with periprocedural complications, such as MI, perforation, atrioventricular blockage and no reflow or slow flow phenomenon. 

Intravascular Lithotripsy (IVL) has been recently introduced as an additional therapeutic alternative. To date, there are no randomized studies to compare RA vs IVL in the treatment of calcified coronary lesions. 

The aim of this prospective, multicenter, non-inferiority study was to compare IVL against RA in terms of plaque modification, stent area and lumen gain, assessed by optical coherence tomography (OCT).

Read also: Post-TAVI Prosthesis-Patient Mismatch.

Primary end point was post procedural minimal stent area (MSA). Secondary end points included mean stent diameter, minimal lumen diameter, mean lumen diameter, minimal lumen area, mean lumen area, mean stent area, minimal stent diameter, stent expansion, eccentricity, fracture, malapposition, troponin levels, procedural time, contrast consumption, radiation dose, target vessel failure (TLF) and target lesion revascularization (TLR) both inhospital and at 1 and 6 month followup. 

In total, the study included 70 patients between 2019 and 2021, who were randomized 1:1. Mean age was 73, and most were men. Stable coronary heart disease was the most common clinical presentation (82%), followed by non ST elevation MI (9.8%), unstable angina (3.3%) and ST acute MI (1.5%). The right coronary artery was treated most often.  The transradial was the most used access site (65.6% while the femoral was used in 37.7% of cases). Predilation was most frequently done in the IVL arm (60% of cases, P= 0.04). There were no significant differences between groups as regards contrast consumption, radiation dose and procedural time. 

Primary end point of MSA resulted similar between groups, though slightly lower in IVL patients (mean: 6.10 mm2, 95% CI: 5.32–6.87 mm2) vs. RA (mean: 6.60 mm2, 95% CI: 5.66–7.54 mm2). 

Read also: Predictors and Evolution of Need for PPM after TAVR with Self-Expanding Valves.

Also, there were no significant differences as regards stent dimension and lumen. However, there was a tendency towards larger stent area with RA vs. IVL (9.52 ± 3.01 mm2 vs. 8.55 ± 2.31 mm2; p = 0.13). There were no differences in stent expansion, malapposition, tissue prolapse or fracture. Lastly, there were no differences in clinical outcomes. 

Conclusion

The use of IVL was shown non-inferior in terms of MSA and stent expansion vs. RA. Also, there were no significant differences in technique induced periprocedural myocardial damage. IVL appears to be an effective therapeutic alternative to approach severely calcified coronary lesions.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.

Reference: F. Blachutzik MD et al Catheter Cardiovasc Interv. 2023;1–11. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...